Esther Baena

1.1k total citations
20 papers, 644 citations indexed

About

Esther Baena is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Esther Baena has authored 20 papers receiving a total of 644 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 6 papers in Molecular Biology and 6 papers in Cancer Research. Recurrent topics in Esther Baena's work include Prostate Cancer Treatment and Research (10 papers), Prostate Cancer Diagnosis and Treatment (6 papers) and Ubiquitin and proteasome pathways (3 papers). Esther Baena is often cited by papers focused on Prostate Cancer Treatment and Research (10 papers), Prostate Cancer Diagnosis and Treatment (6 papers) and Ubiquitin and proteasome pathways (3 papers). Esther Baena collaborates with scholars based in United Kingdom, Spain and United States. Esther Baena's co-authors include Ignacio Moreno de Alborán, Carlos Martı́nez-A, Guo‐Cheng Yuan, Stuart H. Orkin, Roderick T. Bronson, Douglas E. Linn, Mireia Vallespinós, Jonghwan Kim, Zhen Shao and Xin Zhang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Genes & Development.

In The Last Decade

Esther Baena

20 papers receiving 640 citations

Peers

Esther Baena
Barbara Uhl Austria
Beryl Crossley United States
Ashwin Basavaraj United States
Joanne Porte United Kingdom
Esther Baena
Citations per year, relative to Esther Baena Esther Baena (= 1×) peers Jan‐Henrik Mikesch

Countries citing papers authored by Esther Baena

Since Specialization
Citations

This map shows the geographic impact of Esther Baena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esther Baena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esther Baena more than expected).

Fields of papers citing papers by Esther Baena

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esther Baena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esther Baena. The network helps show where Esther Baena may publish in the future.

Co-authorship network of co-authors of Esther Baena

This figure shows the co-authorship network connecting the top 25 collaborators of Esther Baena. A scholar is included among the top collaborators of Esther Baena based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esther Baena. Esther Baena is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baena, Esther, et al.. (2024). The effect of tumor composition on the success of adaptive therapy: The case of metastatic Castrate-Resistant Prostate Cancer. PLoS ONE. 19(9). e0308173–e0308173. 2 indexed citations
2.
Ali, Amin, Hitesh Mistry, Ashwin Sachdeva, et al.. (2024). Tale of two zones: investigating the clinical outcomes and research gaps in peripheral and transition zone prostate cancer through a systematic review and meta-analysis. SHILAP Revista de lepidopterología. 3(1). e000193–e000193. 1 indexed citations
3.
Mével, Renaud, Amin Ali, Pengbo Wang, et al.. (2023). Autocrine activation of MAPK signaling mediates intrinsic tolerance to androgen deprivation in LY6D prostate cancer cells. Cell Reports. 42(4). 112377–112377. 4 indexed citations
4.
Baena, Esther, et al.. (2021). Experimental challenges to modeling prostate cancer heterogeneity. Cancer Letters. 524. 194–205. 17 indexed citations
5.
Villegas-Méndez, Ana, Nicholas Stafford, Michael Haley, et al.. (2021). The plasma membrane calcium ATPase 4 does not influence parasite levels but partially promotes experimental cerebral malaria during murine blood stage malaria. Malaria Journal. 20(1). 297–297. 10 indexed citations
6.
Ali, Amin, et al.. (2021). Prostate zones and cancer: lost in transition?. Nature Reviews Urology. 19(2). 101–115. 41 indexed citations
7.
Mével, Renaud, Susan Mason, Laura C.A. Galbraith, et al.. (2020). RUNX1 marks a luminal castration-resistant lineage established at the onset of prostate development. eLife. 9. 27 indexed citations
8.
Lie‐A‐Ling, Michael, Renaud Mével, Rahima Patel, et al.. (2020). RUNX1 Dosage in Development and Cancer.. PubMed. 43(2). 126–138. 19 indexed citations
9.
Barros‐Silva, João D., Douglas E. Linn, Guoji Guo, et al.. (2018). Single-Cell Analysis Identifies LY6D as a Marker Linking Castration-Resistant Prostate Luminal Cells to Prostate Progenitors and Cancer. Cell Reports. 25(12). 3504–3518.e6. 64 indexed citations
10.
Wang, Pengbo, Craig J. Williams, Rafael Samaniego, et al.. (2018). WDR5 modulates cell motility and morphology and controls nuclear changes induced by a 3D environment. Proceedings of the National Academy of Sciences. 115(34). 8581–8586. 70 indexed citations
11.
Ali, Adnan, et al.. (2017). Identification and evaluation of clinically significant prostate cancer. Current Opinion in Urology. 27(3). 217–224. 7 indexed citations
12.
Lessard, Samuel, Mélissa Beaudoin, Patrick G. Schupp, et al.. (2017). An erythroid-specific ATP2B4 enhancer mediates red blood cell hydration and malaria susceptibility. Journal of Clinical Investigation. 127(8). 3065–3074. 44 indexed citations
13.
Antonello, Jenny, Jakub Chudziak, Alan Redfern, et al.. (2017). Abstract 5685: An evaluation of DNA and RNA based blood biomarkers in prostate cancer. Cancer Research. 77(13_Supplement). 5685–5685. 1 indexed citations
14.
Bonet, Josep Maria, et al.. (2014). Intervention to improve social and family support for caregivers of dependent patients: ICIAS study protocol. BMC Family Practice. 15(1). 53–53. 27 indexed citations
15.
Baena, Esther, Zhen Shao, Douglas E. Linn, et al.. (2013). ETV1 directs androgen metabolism and confers aggressive prostate cancer in targeted mice and patients. Genes & Development. 27(6). 683–698. 139 indexed citations
16.
Vallespinós, Mireia, David Fernández‐Antorán, Lorena Rodríguez, et al.. (2011). B Lymphocyte Commitment Program Is Driven by the Proto-Oncogene c-myc. The Journal of Immunology. 186(12). 6726–6736. 31 indexed citations
17.
Baena, Esther, et al.. (2007). c-Myc is essential for hematopoietic stem cell differentiation and regulates Lin−Sca-1+c-Kit− cell generation through p21. Experimental Hematology. 35(9). 1333–1343. 36 indexed citations
18.
Moreno-Egea, Alfredo, et al.. (2005). Evaluation of the mesh fixation technique in laparoscopic incisional hernioplasty. TSpace (University of Toronto). 1 indexed citations
19.
Baena, Esther, Alberto Gandarillas, Mireia Vallespinós, et al.. (2005). c-Myc regulates cell size and ploidy but is not essential for postnatal proliferation in liver. Proceedings of the National Academy of Sciences. 102(20). 7286–7291. 76 indexed citations
20.
Alborán, Ignacio Moreno de, Esther Baena, & Carlos Martı́nez-A. (2003). c-Myc-deficient B lymphocytes are resistant to spontaneous and induced cell death. Cell Death and Differentiation. 11(1). 61–68. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026